Aurora is a rapidly growing pharmaceutical company focused in bringing to the Asia Pacific region the most advanced medicines and therapies in Dermatology, Respiratory health and Women's health. 

Through our pharmacy division Auragen, our focus is on OTC products that are truly innovative and superior in efficacy, convenience or cost.

To achieve this goal, Aurora acquires or in-licenses products from leading edge pharmaceutical companies from around the world, principally small to medium sized pharmaceutical and biotechnology companies with innovative products.

Aurora aims to be the partner of choice for these emerging new companies.

Our factors of distinctiveness are:
 

•	Ethical and professional standards. We observe the highest professional and ethical standards in everything we do;
•	Local market knowledge and relationships. The Aurora management team has a deep understanding of the Local pharmaceutical market dynamics, current and emerging competitive environment and evolution of the regulatory framework and government health policy. We also leverage our relationships with wholesalers, key hospital chains and opinion leaders amongst specialist physicians;
•	Innovative sales and marketing approaches. Aurora combines its sales and marketing experience in the pharmaceutical industry with 'out-of-the-box' approaches;
•	Execution capability. Aurora is obsessed with execution. Aurora's management has extensive hands-on experience and a solid track record in the key areas of sales, marketing, and regulatory;
•	Focus. Aurora has a limited number of strategic partnerships planned, which allows us to be strongly focused on our brands.